Liposome-encapsulated CpG enhances antitumor activity accompanying the changing of lymphocyte populations in tumor via intratumoral administration

Cited 14 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorD H Kim-
dc.contributor.authorC Moon-
dc.contributor.authorS S Oh-
dc.contributor.authorS Park-
dc.contributor.authorJ W Jeong-
dc.contributor.authorS Kim-
dc.contributor.authorHee Gu Lee-
dc.contributor.authorH J Kwon-
dc.contributor.authorK D Kim-
dc.date.accessioned2017-04-19T10:16:12Z-
dc.date.available2017-04-19T10:16:12Z-
dc.date.issued2015-
dc.identifier.issn2159-3337-
dc.identifier.uri10.1089/nat.2014.0509.ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/13064-
dc.description.abstractAlthough oligodeoxynucleotides containing CpG motifs (CpG-ODN) are potent immune stimulators, the use of natural CpG-ODN--phosphodiester-backbone CpG--has been limited due to its instability by nuclease in vivo. The aim of this study is to investigate the anticancer efficiency of CpG-ODN capsulated using liposome, which enhances the stability of CpG-ODN. We formulated lipoplex, encapsulated natural CpG-ODN from Mycobacterium bovis with liposome, and tested its immune stimulatory activity in vitro and in vivo. The lipoplex induced a systemic innate immune response in vivo and stimulated dendritic cells, but not macrophages, to stimulate proinflammatory cytokines such as tumor necrosis factor alpha and interleukin-6 in vitro. As expected, the lipoplex effectively mediated the prolonged cancer-therapeutic activity against B16 melanoma, which was dependent on natural killer and CD8(+) T cells. The therapeutic activity was observed after only intratumoral administration of lipoplex among several treatment routes. Intratumoral treatment of lipoplex significantly increased the populations of natural killer and CD8(+) T cells and reduced regulatory CD4(+) T cell recruitment, which was correlated with expression profiles of chemokines (CCL1, CCL3, CXCL1, CXCL10, and CCL22). The antitumor therapeutic effect of lipoplex was dependent on the altered lymphocyte population that might be developed by the profile of intratumoral chemokine expression.-
dc.publisherMary Ann Liebert, Inc-
dc.titleLiposome-encapsulated CpG enhances antitumor activity accompanying the changing of lymphocyte populations in tumor via intratumoral administration-
dc.title.alternativeLiposome-encapsulated CpG enhances antitumor activity accompanying the changing of lymphocyte populations in tumor via intratumoral administration-
dc.typeArticle-
dc.citation.titleNucleic Acid Therapeutics-
dc.citation.number2-
dc.citation.endPage102-
dc.citation.startPage95-
dc.citation.volume25-
dc.contributor.affiliatedAuthorHee Gu Lee-
dc.contributor.alternativeName김동혁-
dc.contributor.alternativeName문채린-
dc.contributor.alternativeName오상석-
dc.contributor.alternativeName박수종-
dc.contributor.alternativeName정진우-
dc.contributor.alternativeName김석-
dc.contributor.alternativeName이희구-
dc.contributor.alternativeName권형주-
dc.contributor.alternativeName김광동-
dc.identifier.bibliographicCitationNucleic Acid Therapeutics, vol. 25, no. 2, pp. 95-102-
dc.identifier.doi10.1089/nat.2014.0509-
dc.description.journalClassY-
Appears in Collections:
Division of Biomedical Research > Immunotherapy Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.